Does Machine Unlearning Preserve Clinical Safety? A Risk Analysis for Medical Image Classification
Authors: Andreza M. C. Falcao, Filipe R. Cordeiro
Organizations: Visual Computing Lab, Departamento de Computacao, Universidade Federal Rural de Pernambuco (UFRPE), Brasil
Abstract
The application of Deep Learning in medical diagnosis must balance patient safety with compliance with data protection regulations. Machine Unlearning enables the selective removal of training data from deployed models. However, most methods are validated primarily through efficiency and privacy-oriented metrics, with limited attention to clinically asymmetric error costs. In this work, we investigate how unlearning affects clinical risk in binary medical image classification. We show that standard unlearning strategies (Fine-Tuning, Random Labeling, and SalUn) may reduce test utility while increasing false-negative rates, thereby amplifying clinical risk. To mitigate this, we propose SalUn-CRA (Clinical Risk-Aware), a variant of SalUn that replaces random relabeling with entropy-based forgetting for malignant samples in the forget set, preventing the model from learning harmful benign associations. We evaluate on DermaMNIST and PathMNIST medical image datasets under 20% and 50% data removal. Using Global Risk metrics with asymmetric costs, SalUn-CRA achieves lower or comparable clinical risk to full retraining while preserving unlearning effectiveness. These results suggest that clinical risk should be an integral component of unlearning validation in medical systems.
Language models trained for clinical disease inference are trained on patient data, which may include sensitive and private information, and data owners may request the removal of their data from a trained model due to privacy or copyright concerns. However, exactly unlearning patient-specific data is intractable, and retraining with minor data removal is resource-intensive. While there exists several machine unlearning methods that can be used, their utility is generally restricted to non-medical domains. Moreover, the existing benchmarks for evaluating such unlearning methods primarily utilize synthetically curated datasets, which are not truly representative of real-world systems. Hence, the effectiveness of these unlearning methods in the medical domain is largely unclear. To this end, we introduce REMEDI, an extensive benchmark for machine unlearning tailored to multi-label and multiclass clinical disease inference, where label correlations, longitudinal structure, and safety constraints make unlearning particularly challenging. Unlike the existing benchmarks, REMEDI considers: (1) a relevant application domain (medical), (2) comprehensive unlearning setups involving diverse sets of forget instances, (3) challenging unlearning scenarios including multi-label and multi-class classification tasks, and (4) evaluation metrics involving performance both in terms of utility and extent of unlearning achieved. REMEDI is developed using the MIMIC-III clinical database that contains comprehensive clinical data of patients. Experiments with existing unlearning methods indicate that there exists a trade-off between utility and unlearning performance. They are also largely unsuited to multi-label classification tasks. To facilitate reproducibility, we make our benchmark publicly available.
Anurag Sharma, Sai Teja Chunchu, Prasenjit Mitra +2
With new data privacy laws such as the General Data Protection Regulation (GDPR) [1] that allow individuals to ask that any of their personal information be erased from trained machine learning models, there has been a push to investigate the unlearning of data from models as a way to comply with these laws. In this regard, based on four mechanics, we consider several approximate unlearning strategies applied to the MRBrainS18 dataset [2]. We use a 3D ResNet-50 [3] as a backbone architecture for segmentation that has been pre-trained with the Med3D framework [4]. Considering the pre-trained model as a baseline, we evaluate respective retention accuracy on 2 types of subjects, i.e., retain and forget. We assess these approaches through their Dice similarity coefficient and mean absolute error (MAE) values using two separate training horizons 20 and 50 epochs. The results show that the Noisy Label strategy had the best overall trade-off with a decrease of 93% in the forget set while maintaining 84% accuracy for the retained set after 50 epochs. All other strategies showed extreme levels of forgetting at higher epoch numbers while also demonstrating catastrophic degradation of their retain set performance. The results of this study provide a strict baseline of performance metrics for unlearning on a subject-specific level and provide practitioners with clear criteria for selecting the proper strategies.
As deep learning models become fundamental to modern healthcare, the "Right to be Forgotten" mandated by privacy regulations like GDPR and HIPAA necessitates effective machine unlearning (MU) to remove sensitive patient data from trained models. However, existing MU techniques often struggle with a fundamental "privacy-efficiency-utility" (PEU) trilemma, particularly in medical scenarios where data is frequently characterized by severe class imbalance and long-tailed distributions. In such cases, standard unlearning methods can fail to protect key clinical knowledge or mistakenly delete features essential for diagnosing rare conditions due to the gradient dominance of majority classes. To address these challenges, we propose GRIN+, a novel machine unlearning framework designed for fast and precise data erasure in imbalanced medical scenarios. GRIN+ decouples unlearning-specific knowledge from generalized representations at the parameter level by analyzing the gradient contributions of both "forget" and "retain" sets. It introduces a class-adaptive influence scoring mechanism to rectify gradient dominance and employs a direction-constrained update strategy to prevent the unintended erosion of vital clinical knowledge. Comprehensive benchmarking across multiple medical datasets, including skin cancer (ISIC), brain tumor (MRI), and breast ultrasound (BUSI), demonstrates that GRIN+ achieves an optimal balance of the PEU trilemma. Experimental results show that GRIN+ maintains high diagnostic accuracy and robust privacy while significantly enhancing runtime efficiency compared to existing baselines. We open-source the GRIN+ code and benchmarks to support further research.